Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,2317059,Aia15,Adjuvant induced arthritis QTL 15,2.46,,joint integrity trait (VT:0010548),right rear ankle joint diameter (CMO:0002150),7,55072862,69399731,Rat,n/a,region,qtl 1000,1641912,Alcrsp18,Alcohol response QTL 18,,,response to alcohol trait (VT:0010489),duration of loss of righting reflex (CMO:0002289),5,35788756,147487820,Rat,n/a,region,qtl 1000,1641922,Alcrsp8,Alcohol response QTL 8,,,alcohol metabolism trait (VT:0015089),blood ethanol level (CMO:0000535),5,35788756,70742105,Rat,n/a,region,qtl 1000,1641885,Alcrsp9,Alcohol response QTL 9,,,alcohol metabolism trait (VT:0015089),blood ethanol level (CMO:0000535),7,31381529,76381529,Rat,n/a,region,qtl 1000,634336,Anxrr17,Anxiety related response QTL 17,3.66,,locomotor behavior trait (VT:0001392),number of entries into a discrete space in an experimental apparatus (CMO:0000960),7,2920071,124838025,Rat,n/a,region,qtl 1000,738033,Anxrr6,Anxiety related response QTL 6,4.1,,exploratory behavior trait (VT:0010471),percentage of entries into a discrete space in an experimental apparatus (CMO:0000961),7,22168412,67168412,Rat,n/a,region,qtl 1000,738030,Anxrr8,Anxiety related response QTL 8,4.1,,exploratory behavior trait (VT:0010471),number of entries into a discrete space in an experimental apparatus (CMO:0000960),7,54259512,99259512,Rat,n/a,region,qtl 1000,1578652,Bmd15,Bone mineral density QTL 15,5.2,,femur mineral mass (VT:0010011),trabecular volumetric bone mineral density (CMO:0001729),7,12687850,67801690,Rat,n/a,region,qtl 1000,2293685,Bmd21,Bone mineral density QTL 21,4.2,0.0003,femur mineral mass (VT:0010011),total volumetric bone mineral density (CMO:0001728),7,55495689,100495689,Rat,n/a,region,qtl 1000,2293644,Bmd29,Bone mineral density QTL 29,5.4,0.0001,femur size trait (VT:1000369),femoral neck cross-sectional area (CMO:0001697),7,55495689,100495689,Rat,n/a,region,qtl 1000,2293696,Bmd32,Bone mineral density QTL 32,5.1,0.0001,femur strength trait (VT:0010010),femoral neck polar moment of inertia (CMO:0001670),7,55495689,100495689,Rat,n/a,region,qtl 1000,2300178,Bmd54,Bone mineral density QTL 54,5.3,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),7,55495689,100495689,Rat,n/a,region,qtl 1000,1300132,Bp182,Blood pressure QTL 182,3.49,,arterial blood pressure trait (VT:2000000),blood pressure time series experimental set point of the baroreceptor response (CMO:0002593),7,25365633,93155402,Rat,n/a,region,qtl 1000,1358895,Bp254,Blood pressure QTL 254,3.6,0.0003,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),5,60072951,133313852,Rat,n/a,region,qtl 1000,10402855,Bp379,Blood pressure QTL 379,,0.21,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),7,35867729,80867729,Rat,n/a,region,qtl 1000,61357,Bp38,Blood pressure QTL 38,1.6,0.052,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),7,48118835,128611831,Rat,n/a,region,qtl 1000,61386,Bp49,Blood pressure QTL 49,16.6,,cerebrum integrity trait (VT:0010549),brain infarction volume (CMO:0001013),5,61612600,102331727,Rat,n/a,region,qtl 1000,61393,Bp7,Blood pressure QTL 7,4.5,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,61612600,168109659,Rat,n/a,region,qtl 1000,2293678,Bss24,Bone structure and strength QTL 24,6.71,0.0001,femur morphology trait (VT:0000559),femur cross-sectional area (CMO:0001661),7,55495689,100495689,Rat,n/a,region,qtl 1000,2293707,Bss32,Bone structure and strength QTL 32,7.64,0.0001,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),7,55495689,100495689,Rat,n/a,region,qtl 1000,2293667,Bss42,Bone structure and strength QTL 42,7.25,0.0001,lumbar vertebra size trait (VT:0010518),lumbar vertebra cross-sectional area (CMO:0001689),7,55495689,100495689,Rat,n/a,region,qtl 1000,1549840,Bss5,Bone structure and strength QTL 5,9.8,,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),7,32035053,77035053,Rat,n/a,region,qtl 1000,7411561,Bw134,Body weight QTL 134,24,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),5,51804426,96804426,Rat,n/a,region,qtl 1000,7411569,Bw137,Body weight QTL 137,,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),7,28204653,73204653,Rat,n/a,region,qtl 1000,61439,Cia8,Collagen induced arthritis QTL 8,5.1,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),7,32572942,77572942,Rat,n/a,region,qtl 1000,631504,Cm27,Cardiac mass QTL 27,3.45,,heart left ventricle mass (VT:0007031),heart left ventricle wet weight (CMO:0000071),7,50704769,128085642,Rat,n/a,region,qtl 1000,1300149,Cm6,Cardiac mass QTL 6,4.09,,heart mass (VT:0007028),heart left ventricle weight to body weight ratio (CMO:0000530),7,51252005,111589099,Rat,n/a,region,qtl 1000,10755440,Coatc10,Coat color QTL 10,,0,coat/hair pigmentation trait (VT:0010463),pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812),7,13952179,58952179,Rat,n/a,region,qtl 1000,10755451,Coatc11,Coat color QTL 11,,0,coat/hair pigmentation trait (VT:0010463),pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812),7,24731465,69731465,Rat,n/a,region,qtl 1000,10755453,Coatc12,Coat color QTL 12,,0,coat/hair pigmentation trait (VT:0010463),pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812),7,38547706,83547706,Rat,n/a,region,qtl 1000,61359,Eaex,Experimental allergic encephalomyelitis QTL x,3,,nervous system integrity trait (VT:0010566),post-insult time to onset of experimental autoimmune encephalomyelitis (CMO:0001422),5,56902367,101902367,Rat,n/a,region,qtl 1000,7394712,Emca13,Estrogen-induced mammary cancer QTL 13,,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),5,9514842,103580403,Rat,n/a,region,qtl 1000,1576312,Emca8,Estrogen-induced mammary cancer QTL 8,4.1,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),5,51418671,147487820,Rat,n/a,region,qtl 1000,9589025,Epfw7,Epididymal fat weight QTL 7,20.66,0.001,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),5,51804426,96804426,Rat,n/a,region,qtl 1000,1576314,Eutr1,Estrogen induced uterine response QTL 1,,,uterus integrity trait (VT:0010575),pyometritis severity score (CMO:0002009),5,1525098,78720537,Rat,n/a,region,qtl 1000,1576317,Eutr2,Estrogen induced uterine response QTL 2,,0.01,uterus integrity trait (VT:0010575),pyometritis severity score (CMO:0002009),5,35225432,108092802,Rat,n/a,region,qtl 1000,7411605,Foco14,Food consumption QTL 14,24.1,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),7,40872682,85872682,Rat,n/a,region,qtl 1000,1598807,Glom12,Glomerulus QTL 12,2.7,,kidney glomerulus morphology trait (VT:0005325),index of glomerular damage (CMO:0001135),5,34402409,79402409,Rat,n/a,region,qtl 1000,2303574,Gluco42,Glucose level QTL 42,2,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),5,55903593,100903593,Rat,n/a,region,qtl 1000,2316959,Gluco59,Glucose level QTL 59,4.7,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),5,35661945,117554267,Rat,n/a,region,qtl 1000,634326,Hc3,Hypercalciuria QTL 3,2.1,,urine calcium amount (VT:0002985),urine calcium excretion rate (CMO:0000763),7,50252103,95252103,Rat,n/a,region,qtl 1000,1300115,Hrtrt7,Heart rate QTL 7,2.76,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),5,48722038,93587756,Rat,n/a,region,qtl 1000,1300138,Hrtrt9,Heart rate QTL 9,4.72,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),7,35867729,61047824,Rat,n/a,region,qtl 1000,10059592,Kidm45,Kidney mass QTL 45,3.95,0.025,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),7,14445685,59445685,Rat,n/a,region,qtl 1000,10059605,Kidm47,Kidney mass QTL 47,2.91,0.05,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),7,54534996,73293934,Rat,n/a,region,qtl 1000,1300179,Kidm5,Kidney mass QTL 5,3.51,,kidney mass (VT:0002707),left kidney wet weight (CMO:0000083),7,51251919,145729302,Rat,n/a,region,qtl 1000,1302786,Kidm8,Kidney mass QTL 8,28.15,,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),5,34402409,79402409,Rat,n/a,region,qtl 1000,631534,Lnnr1,Liver neoplastic nodule remodeling QTL 1,3.85,0.001,liver integrity trait (VT:0010547),liver remodeling tumorous lesion number to liver total tumorous lesion number ratio (CMO:0001705),7,40872682,85872682,Rat,n/a,region,qtl 1000,634305,Mamtr1,Mammary tumor resistance QTL 1,,0.0001,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),5,12651967,117554267,Rat,n/a,region,qtl 1000,70189,Mcs5,Mammary carcinoma susceptibility QTL 5,10.51,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),5,56991667,137729065,Rat,n/a,region,qtl 1000,70190,Mcs6,Mammary carcinoma susceptibility QTL 6,2.29,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),7,33044449,71352127,Rat,n/a,region,qtl 1000,2298547,Neuinf5,Neuroinflammation QTL 5,3.7,,nervous system integrity trait (VT:0010566),spinal cord Cd74 protein level (CMO:0002131),7,12328467,67193263,Rat,n/a,region,qtl 1000,70212,Niddm25,Non-insulin dependent diabetes mellitus QTL 25,3.54,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),5,1,136640934,Rat,n/a,region,qtl 1000,1643004,Pain2,Pain QTL 2,1,,mechanical nociception trait (VT:0002734),self mutilation severity score (CMO:0002145),7,12328467,106995532,Rat,n/a,region,qtl 1000,8552954,Pigfal14,Plasma insulin-like growth factor 1 level QTL 14,9,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),5,21904363,66904363,Rat,n/a,region,qtl 1000,2316957,Pur21,Proteinuria QTL 21,6.2,,urine protein amount (VT:0005160),urine protein level (CMO:0000591),5,61086653,117554114,Rat,n/a,region,qtl 1000,2316952,Pur22,Proteinuria QTL 22,5.2,,urine protein amount (VT:0005160),urine protein level (CMO:0000591),7,55072862,123602998,Rat,n/a,region,qtl 1000,1331801,Rf33,Renal function QTL 33,4.149,,kidney blood vessel physiology trait (VT:0100012),absolute change in renal vascular resistance (CMO:0001900),5,44404276,134502294,Rat,n/a,region,qtl 1000,1331756,Rf34,Renal function QTL 34,4.16275,,kidney blood vessel physiology trait (VT:0100012),absolute change in renal blood flow rate (CMO:0001168),5,1,93273395,Rat,n/a,region,qtl 1000,1331771,Rf35,Renal function QTL 35,4.36965,,kidney blood vessel physiology trait (VT:0100012),absolute change in renal blood flow rate (CMO:0001168),5,1,89432042,Rat,n/a,region,qtl 1000,2316954,Rf57,Renal function QTL 57,0,,kidney glomerulus morphology trait (VT:0005325),index of glomerular damage (CMO:0001135),5,61086653,93273130,Rat,n/a,region,qtl 1000,2316947,Rf58,Renal function QTL 58,7.8,,kidney glomerulus morphology trait (VT:0005325),index of glomerular damage (CMO:0001135),7,55072862,123602998,Rat,n/a,region,qtl 1000,1298067,Scl15,Serum cholesterol level QTL 15,4.8,0.001,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),5,34402409,79402409,Rat,n/a,region,qtl 1000,61426,Scl2,Serum cholesterol level QTL 2,7.3,0.001,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),5,61086525,149030144,Rat,n/a,region,qtl 1000,1331773,Scl26,Serum cholesterol level QTL 26,3.065,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),5,44404276,89432042,Rat,n/a,region,qtl 1000,61428,Scl3,Serum cholesterol level QTL 3,3.2,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),7,53200344,98200344,Rat,n/a,region,qtl 1000,6903306,Scl35,Serum cholesterol QTL 35,2.6,0.0073,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),5,29641661,74641661,Rat,n/a,region,qtl 1000,1549845,Scl44,Serum cholesterol level QTL 44,6,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),5,40777918,154732375,Rat,n/a,region,qtl 1000,2290448,Scl54,Serum cholesterol level QTL 54,2.93,,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),5,31926122,136640934,Rat,n/a,region,qtl 1000,631513,Scl7,Serum cholesterol level QTL 7,4.1,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),7,45301573,90301573,Rat,n/a,region,qtl 1000,10053722,Scort27,Serum corticosterone level QTL 27,2.41,0.0083,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),7,50793818,95793818,Rat,n/a,region,qtl 1000,1354639,Spl5,Serum phospholipid level QTL 5,3.9,,blood LDL phospholipid amount (VT:0010505),blood low density lipoprotein phospholipid level (CMO:0001568),7,25365633,60317612,Rat,n/a,region,qtl 1000,1358361,Sradr5,Stress Responsive Adrenal Weight QTL 5,5.55,,adrenal gland mass (VT:0010420),both adrenal glands wet weight (CMO:0000164),7,51251919,118477612,Rat,n/a,region,qtl 1000,1358353,Srcrtb2,Stress Responsive Cort Basal QTL 2,3.48,0.003,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),5,18847913,76608178,Rat,n/a,region,qtl 1000,1300127,Srn1,Serum renin concentration QTL 1,3.87,,blood renin amount (VT:0003349),plasma renin activity level (CMO:0000116),7,35867729,93155402,Rat,n/a,region,qtl 1000,2316955,Stl24,Serum triglyceride level QTL 24,7.1,,blood triglyceride amount (VT:0002644),plasma triglyceride level (CMO:0000548),7,55072862,123602998,Rat,n/a,region,qtl 1000,6903292,Stl28,Serum triglyceride level QTL 28,2.6,0.0073,blood triglyceride amount (VT:0002644),plasma triglyceride level (CMO:0000548),5,29641661,74641661,Rat,n/a,region,qtl 1000,1578767,Stresp17,Stress response QTL 17,4.3,0.01,blood aldosterone amount (VT:0005346),plasma aldosterone level (CMO:0000551),5,29078899,74078899,Rat,n/a,region,qtl 1000,1578776,Stresp18,Stress response QTL 18,2.9,,thymus mass (VT:0004954),thymus wet weight (CMO:0000855),5,29078899,74078899,Rat,n/a,region,qtl 1000,1578766,Tcas11,Tongue tumor susceptibility QTL 11,4.12,,tongue integrity trait (VT:0010553),number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950),5,47745646,167946134,Rat,n/a,region,qtl 1000,2303629,Vencon3,Ventilatory control QTL 3,7.25,,respiration trait (VT:0001943),respiration rate (CMO:0000289),7,47895099,63372754,Rat,n/a,region,qtl 1000,2303615,Vencon7,Ventilatory control QTL 7,,0.001,respiration trait (VT:0001943),respiration rate (CMO:0000289),5,53309568,98309568,Rat,n/a,region,qtl 1000,8662454,Vetf3,Vascular elastic tissue fragility QTL 3,27.4,,artery integrity trait (VT:0010639),number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries (CMO:0002562),5,1666587,71552720,Rat,n/a,region,qtl